Optimal care of cardiovascular disease and type 2 diabetes patients: Shared responsibilities between the cardiologist and diabetologist

Atherosclerosis Supplements

Volumn 7, Issue 1 SPEC. ISS., 2006, Pages 37-42

  Leiter, Lawrence A ^a   Fitchett, David ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Cardiologist; Cardiovascular risk; Diabetologist; Mortality; Outcome; Shared care; Type 2 diabetes

Indexed keywords

ATORVASTATIN; FENOFIBRATE; GEMFIBROZIL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACUTE CORONARY SYNDROME; BLOOD GLUCOSE MONITORING; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DYSLIPIDEMIA; HUMAN; HYPERGLYCEMIA; HYPERTENSION; LIFESTYLE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; REVIEW; RISK REDUCTION; SMOKING; STROKE;

EID: 33645085273     PISSN: 15675688     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosissup.2006.01.006     Document Type: Article

References (42)

1. M. Stern Diabetes and cardiovascular disease. The "common soil" hypothesis Diabetes 44 1995 369 374
2. S. Haffner, S. Lehto, and T. Ronnemaa Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction N Engl J Med 339 1998 229 234
3. J. Beckman, M. Creager, and P. Libby Diabetes and atherosclerosis. Epidemiology, pathophysiology and management JAMA 287 2002 2570 2581
4. S. Grundy, B. Brewer, and J. Cleeman Definition of metabolic syndrome. Report of the NHLBI/AHA conference on scientific issues related to definition Circulation 109 2004 433 438
5. J. McKinlay, and L. Marceau US public health and the 21st century: diabetes mellitus Lancet 356 2000 757 761
6. M. Bartnik, K. Malmberg, and L. Ryden Recognising and treating the diabetic patient in cardiovascular care Eur J CV Nurs 1 2002 171 181
7. T. Inoguchi, T. Yamashita, and F. Umeda High incidence of silent myocardial ischaemia in elderly patients with non insulin-dependent diabetes mellitus Diabetes Res Clin Pract 47 2000 37 44
8. J. Stamler, O. Vaccaro, J. Neaton, and D. Wentworth Diabetes, other risk factors, and 12-year cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial Diabetes Care 16 1993 434 444
9. E. Van Belle, C. Bauters, and E. Hubert Restenosis rates in diabetic patients: a comparison of coronary stenting and balloon angioplasty in native coronary vessels Circulation 96 1997 1454 1460
10. J. Silva, S. Ramee, and C. White Primary stenting in acute myocardial infarction: influence of diabetes mellitus in angiographic results and clinical outcome Am Heart J 138 1999 446 455
11. I. Stratton, A. Adler, and H. Neil Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study BMJ 321 2000 405 412
12. R. Turner, H. Millns, and H. Neil Risk factors for coronary artery disease in non insulin-dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23) BMJ 316 1998 823 828
13. Hypertension in Diabetes Study (HDS): I. Prevalence of hypertension in newly presenting type 2 diabetic patients and the association with risk factors for cardiovascular and diabetic complications. J Hypertens 1993;11:309-17.
14. A. Adler, I. Stratton, and H. Neil Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study BMJ 321 2000 412 419
15. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998;317:703-13.
16. J. Tuomilehto, D. Rastenyte, and W.H. Birkenhager Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. Systolic Hypertension in Europe Trial Investigators N Engl J Med 340 1999 677 684
17. H. Ginsberg, Y. Zhang, and A. Hernandez-Ono Regulation of plasma triglycerides in insulin resistance and diabetes Arch Med Res 36 2005 232 240
18. S. Robins, D. Collins, and J. Wittes Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial JAMA 285 2001 1585 1591
19. H. Bloomfield Rubins, J. Davenport, and V. Babikian Reduction in stroke with gemfibrozil in men with coronary heart disease and low HDL cholesterol: The Veterans Affairs HDL Intervention Trial (VA-HIT) Circulation 103 2001 2828 2833
20. A. Keech, R.J. Simes, and P. Barter Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial Lancet 366 2005 1849 1861
21. H. Colhoun After FIELD: should fibrates be used to prevent cardiovascular disease in diabetes? Lancet 366 November (9500) 2005 1829 1831
22. R. Collins, J. Armitage, and S. Parish MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial Lancet 361 2003 2005 2016
23. H. Colhoun, D. Betteridge, and P. Durrington Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial Lancet 364 2004 685 696
24. K. Pyorala, T. Pedersen, and J. Kjekshus Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S) Diabetes Care 20 1997 614 620
25. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. N Engl J Med 1998;339:1349-57.
26. J.W. Blasetto, E.A. Stein, and W.V. Brown Efficacy of rosuvastatin compared with other statins at selected starting doses in hypercholesterolaemic patients and in special population groups Am J Cardiol 91 Suppl. 2003 3C 10C
27. C.A. Reasner What is the most effective strategy for managing diabetic dyslipidaemia? Atheroscler Suppl 6 2005 21 27
28. K. Malmberg, A. Norhammar, H. Wedel, and L. Ryden Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction. Long-term results from the diabetes and insulin-glucose infusion in acute myocardial infarction (DIGAMI) study Circulation 99 1999 2626 2632
29. A. Norhammar, A. Tenerz, and G. Nilsson Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study Lancet 359 2002 2140 2144
30. S. Capes, D. Hunt, K. Malmberg, and H. Gerstein Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview Lancet 355 2000 773 778
31. I. Stranders, M. Diamant, and R. van Gelder Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus Arch Intern Med 164 2004 982 988
32. K. Malmberg, L. Ryden, and S. Efendic Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year J Am Coll Cardiol 26 1995 57 65
33. K. Malmberg Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group BMJ 314 1997 1512 1515
34. K. Malmberg, L. Ryden, and H. Wedel Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity Eur Heart J 26 2005 650 661
35. G. Van den Berghe, P. Wouters, and F. Weekers Intensive insulin therapy in the critically ill patient N Engl J Med 345 2001 1359 1367
36. J. Barzilay, C. Spiekerman, and L. Kuller Prevalence of clinical and isolated subclinical cardiovascular disease in older adults with glucose disorders Diabetes Care 24 2001 1233 1239
37. American Diabetes Association Consensus development conference on the diagnosis of coronary heart disease in people with diabetes Diabetes Care 21 1998 1551 1559
38. P. Gaede, P. Vedel, and N. Larsen Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes N Engl J Med 348 2003 383 393
39. Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease: the Bypass Angioplasty Revascularization Investigation (BARI). Circulation 1997;96:1761-9.
40. C. Fox, S. Coady, and P. Sorlie Trends in cardiovascular complications of diabetes JAMA 292 2004 2495 2499
41. M. Bartnik, L. Ryden, and R. Ferrari The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart Eur Heart J 25 2004 1880 1890
42. D. Aguilar, S. Solomon, and L. Kober Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial Circulation 110 2004 1572 1578